Journalists: For links to video and audio files, see the bottom of this post.
Paul Croarkin, D.O., is researching transcranial magnetic stimulation (TMS), a non-invasive technique which sends magnetic pulses into areas of the brain where depression lives. However, he is studying something a bit different, an objective measure to gauge how well the therapy is working. He’s looking for a definitive change, or biomarker, in the brain.
Dr. Croarkin is especially interested in studying TMS because patients say it’s so tolerable, especially among adolescents. When Dr. Croarkin quizzed kids participating in a TMS clinical trial about the nuisance of the therapy, they rated it slightly above a long car ride. Objectively discovering how well a patient is reacting to a medical therapy such as TMS also allows doctors to better personalize treatment plans for each individual.
Dr. Croarkin has conducted preliminary studies to measure measure how chemicals in the brain associated with depression (biomarkers) are reacting to TMS. Although it’s still early, his initial findings are showing that TMS is working – not just subjectively.
Journalists: The following video and audio clip with Dr. Croarkin outlining his vision for TMS is available for download and use in your stories.
Below is a link to an edited youtube video with Dr. Croarkin that you can embed with your stories.